Newsfeeds - Spark Newswire

2 minute read

Dr. Reddy’s Labs, MediCane Health Report Launch Of Medical Cannabis Products In Germany

Today, 4:07 AM

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021. Dr. Reddy's will be the exclusive distributor of several of MediCane's medical cannabis products in

RDY

32 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 4:07 AM

On Monday, 524 stocks hit new 52-week lows.

AAL

22 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:07 AM

On Friday, 368 stocks hit new 52-week lows.

AAL

7 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 4:07 AM

Wednesday's session saw 107 companies set new 52-week lows.

ADAP

7 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:07 AM

During Tuesday's trading, 98 companies set new 52-week lows.

AAON

2 minute read

Earnings Scheduled For January 28, 2022

By Benzinga Insights

Today, 4:07 AM

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its third quarter.

ABTX

1 minute read

Reddy’s To Launch Generic Version Of Merck’s COVID-19 Drug At $0.50/Pill: Reuters

By Vandana Singh

Today, 4:07 AM

India-based Dr Reddy's Laboratories Ltd (NYSE: RDY) will launch its generic version of Merck Co & Inc's (NYSE: MRK) COVID-19 antiviral pill,

MRK

1 minute read

Dr Reddy’s Laboratories To Launch Generic Version Of Merck’s Oral COVID-19 Pill At $0.4693/Capsule

By Bill Haddad

Today, 4:07 AM

-Reuters

RDY

1 minute read

Dr. Reddy’s Laboratories Receives DCGI Approval To Launch Molnupiravir Capsules 200mg Molflu In India

By Bill Haddad

Today, 4:07 AM

https://www.drreddys.com/media/1057220/press-release-dr-reddys-molnupiravir.pdf

RDY

1 minute read

FDA
News

Dr Reddy’s Laboratories Says Received Approval From U.S. FDA For Anda 207577

By Benzinga Newsdesk

Today, 4:07 AM

-SEC Filing

RDY